There has been a theory long believed that testosterone is not good for men suffering from prostate cancer, especially after the hormone was linked to growths of tumors in prostate cancer patients since the 1940s. In fact, one of the most used treatments for prostate cancer involves the blockage of testosterone from the system, and is called androgen depravation therapy.
• A survey:A total of 82 men who are hypogonadal and were patients who suffered from prostate cancer were identified. They had a median age of about seventy-seven years. They were all given testosterone therapy and the median follow up period was forty-one months. This was the first survey of its kind, and was based on the idea of modern research, which pondered why testosterone therapy for men who had prostate cancer was such a bad idea. This analysis of the antipathy against it was published in the journal of urology. • The effects of testosterone therapy: Giving men of a greater age a supply of testosterone is controversial but it’s happening in the U.S. The lack of testosterone in needed quantities, or hypogonadism, is seen more prevalently, with the increasing age in men. This is characterized by a decrease in muscle mass, an increase in fat stockpiled in the body and weight, a lowered sex drive, and increased fatigue. However, these symptoms reduced drastically when the body was supplemented with testosterone. • Observations made: Contrary to the notion that testosterone makes prostate cancer worsen, patients who underwent testosterone therapy showed no upgrades to an increased Gleason Score as future biopsies were taken, and none of them had definitive treatments for prostate cancer, and even though six percent of men suffered a relapse, this could be due to the biological nature of the tumor and disease. This is also way below the clinical normative values. Further research is needed before testosterone therapy can be considered close to a viable alternative, but contrary to past belief, it isn’t damning either.
0 Comments
Prostate cancer is one of the most common types of cancer to affect men. The diseaseis among one of the leading causes of cancer-related deaths in men, with critical statistics pointing out about one man in 38 die due to prostate cancer. This type of cancer mainly affects older men; about 6 cases in 10 are diagnosed in men within the age 61 years or older. Prostate cancer is a critical disease, but when diagnosed and treated early, it is not fatal.
Early cancer detection often gives room for more treatment options and provides a patient with better survival chances. This is because once a patient starts treatmentearly, cancer cells can be quickly killed. A simple blood test called the prostate-specific antigen (PSA) is used to test for prostate cancer, a digital rectal exam (DRE) can also be used as a part of the screening. Future screenings depend on the results of a prostate-specific antigen test: • Men who take the screening test and have a PSA under 2.5 ng/mL should go for retestingevery two years. • Its advisable to undergo Screening annually for men with a PSA level of at least 2.5 ng/mL. • All men who are over 55 years of age should undergo testing because prostate cancer usually shows no signs and symptoms in its early ages. Prostate cancer in its early stages usually shows no symptoms, but if they do occur, they may include: • Strain when urinating • Delays and burning sensation while passing urine • Loss of bladder control • A weak stream of urine • Urinating more often than usual • Blood in urine • Pain and stiffness in the lower back It is essential to see your doctor as soon as possible to seek medical attention if you are experiencing the symptoms listed above. |
AuthorAs the founder and medical director of the Prostate Seed Institute Dr. Gregory A. Echt. His vision to provide the most modern treatment, non surgical treatments for prostate cancer in various locations throughout the Dallas-Fort Worth continues to succeed. Now date, he has made a therapy for prostate implantation seed at over 2,500 men, including urologists and oncologists. Archives
December 2019
Categories |